FDA approves first-ever vaccine for Ebola prevention

Published December 20, 2019 1:59pm ET



The U.S. Food and Drug Administration for the first time approved a vaccine that protects against the deadly Ebola virus.

The vaccine, Ervebo, is for the prevention of Ebola virus disease caused by Zaire ebolavirus in people 18 and older, the agency said Thursday.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.